mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Concurrent validity of self-report measures of eating disorders in adolescents with type 1 diabetes

D’Emden H et al. – Preliminary evidence is provided for the validation of the Youth Eating Disorder Examination–Questionnaire (YEDE–Q) and Eating Disorder Inventory–3 Risk Composite (EDI–3RC) for use in adolescents with type 1 diabetes. The YEDE–Q also defines individual disturbed eating behaviours with frequency ratings which can be helpful for tailoring early intervention.

Methods
  • In this cross-sectional study, 124 adolescents with type 1 diabetes aged 13-18 years completed two self-administered questionnaires, the YEDE-Q and the EDI-3RC.
  • Cronbach’s alpha was used to assess internal consistency of the tools.
  • Fifty one adolescents, randomly selected, participated in the chEDE. Intraclass correlations and Spearman’s correlations were used to measure concordance of the chEDE with the YEDE-Q and EDI-3RC.

Results
  • The YEDE-Q and EDI-3RC demonstrated good subscale internal consistency; Cronbach alpha’s for YEDE-Q (0.78 – 0.95) and EDI-3RC (0.79 – 0.94).
  • High levels of concurrent validity with the chEDE were seen with both tools.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close